Navigation Links
China Kangtai Cactus Biotech Retains Hawk Associates for Investor Relations Services
Date:7/6/2009

HARBIN, China, July 6 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of cactus-based consumer products in China, announced today that it has retained the services of Hawk Associates for strategic investor relations. Information about China Kangtai will be available through the Hawk Associates website at: http://www.hawkassociates.com , featuring company updates, investor information and live financial feeds.

China Kangtai CEO Jinjiang Wang said, "We look forward to working with Hawk Associate, which has been providing comprehensive strategic IR services for 14 years in their roles as trusted advisors. We believe Hawk Associates is one of the premier investor relations firms that effectively helps companies successfully communicate their stories to the investment community. The branding and investor relations expertise that Hawk provides will be essential in assisting management in showcasing the true value of our company."

Hawk Associates CEO Frank Hawkins said, "As the dominant producer with 60% market share of China's edible cactus production, China Kangtai is a major beneficiary of growing Chinese demand for health and wellness products. In China, cactus products are traditionally used for treatment for health issues such as diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity and skin disorders. This is a unique company in an unsaturated industry. With the company's recent acquisition in March, Kangtai is seeking to increase its production capabilities in an effort to enhance its overall growth. We are thrilled to be able to help Kangtai tell its story to the investment community to strengthen its long-term valuation."

About China Kangtai Cactus Biotech, Inc.

China Kangtai C
'/>"/>

SOURCE China Kangtai Cactus Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. RainEarth (RNER) Continues to Expand its Marketing Force in China
2. Sinovac Receives Chinas First Influenza A (H1N1) Vaccine Order
3. China-Biotics, Inc. to Join Russell 3000 Index
4. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
5. China Biologic Products Closes the $9.6 Million Private Placement
6. China Biologic Products Enters Into Private Placement Agreements to Raise $9.6 Million
7. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
8. Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China
9. China-Biotics, Inc. to Attend Digestive Disease Week 2009
10. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
11. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...IN, Calif., Dec. 2 Pereg...reported completion of patient enrollment in a dos... in patients with relapsed glioblastoma multiforme...a is a targeted monoclonal antibody linked to a ra...tment for GBM. Cotara specifically targets cells ...
(Date:12/2/2009)... JERUSALEM, Israel, December 2 ...aluating the preclinical (animal study) safety and... technology from Weill,Cornell Medical College and...eat inherited anemias such as Cooley,s Anemia. ,...nologies to expand, ex vivo,populations of stem/p...
(Date:12/2/2009)...SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is... turmoil and uncertainty is part of many,businesse...ustry has been,relatively immune to the economic d..., During the midst of the difficult times... Johnson inaugurated an R&D center in Shanghai...
(Date:12/1/2009)...EW YORK, Dec. 1 Reportlinker.com a...lable in its catalogue: ,, Chromium - Global .../p0164494/Chromium---Global-Market-Trends.html ,...luenced by stainless steel, while growth in aerosp...ortant for growth of chromium metal. Environmental...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...8 ,Neurobiological Technologies, Inc. (NTI(R)) (Na...il 1, 2008, Matthew M. Loar has been appointed Chi...e Company,s headquarters in,Emeryville. Mr. Loar j...ved,as Chief Financial Officer since 2006., "Matt...ficer, and we,will look to his expertise to help g...
...Solutions Holdings PLC,("Plethora", AIM: PLE), the...t and management of urological disorders, today an...t financing agreement with Paul Capital,Healthcare... to $28 million,in cash with $15 million payable u... commercial sale of PSD502 (PLE,s development stag...
... Rx,Corporation (OTC Bulletin Board: PMQC, PMQCU, ...cy services, announced today that it has postponed...lts and discuss 2008 outlook,that was originally s...onal,details about the timing of the 2007 financia...ce call will be forthcoming shortly., About Chem ...
Other Biology Technology:Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer 2Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer 3Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment 2Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment 3Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment 4Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results 2
(Date:12/4/2009)...electroencephalogram (EEG) is widely used by physi...o diagnose neurological disorders. However, it has...n the head give an exact view of what is happening...stitute for Biological Cybernetics in Tbingen, Ger...tivity generated within the brain to that measured...
(Date:12/4/2009)...major discovery is challenging accepted thinking a...ated with diseases such as Alzheimer,s and Parkins...rapeutics. , It was believed that amyloid fibril...imes known as fibres - are inert, but that there m...n damage cells and cause disease. , But in a pa...
(Date:12/3/2009)...r ability to learn new information and adapt to ch...in lifelong memories, appears to lie in the minute...g to a new study by NYU Langone Medicine Center re... in the journal Nature . , The scientists, led...iology and neuroscience at NYU School of Medicine,...
Breaking Biology News(10 mins):How to read brain activity? 2New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2Tianyin Pharmaceutical Co Inc Announces Cash Dividend to Common Stockholders 12933 1Tianyin Pharmaceutical Co Inc Announces Cash Dividend to Common Stockholders 12933 2Sokolove Law Launches Chinese Drywall Consumer Advocacy Hotline 51037 1Sokolove Law Launches Chinese Drywall Consumer Advocacy Hotline 51037 2Stereotaxis Announces Second Quarter 2009 Earnings Release Date and Conference Call 51032 1Stereotaxis Announces Second Quarter 2009 Earnings Release Date and Conference Call 51032 2
...dicine researchers have discovered how new neurons...o regions of the brain where they can replace old ...cell therapies can be specifically targeted to bra...or by stroke. , Associate Professor Qun-Yong Zhou ...ent of Pharmacology have identified a protein that...
...ton University in St. Louis has shown that for som...exual organs, and actually choose them for mating.... sex organ, called a gonopodium. These fish out-co... environment because they have a faster burst spee...ut because the size of their organ slows them down...
... world are breathing a sigh of relief, as they no ...atural disease-fighting substances. Scientists rec...emnii, which lives symbiotically inside the sea sq...compounds that may one day be used in cancer treat...uld not successfully cultivate Prochloron in the l...
Other Biology News:Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2Certain fish have a special mating preference 2Certain fish have a special mating preference 3Certain fish have a special mating preference 4
Blot module from GE Healthcare, formerly Amersham Biosciences
Rat Anti-Human CD66 acd Monoclonal Antibody, Unconjugated, Clone YTH71.3 from GeneTex
LB Broth Base powder (Lennox L Broth Base) from Invitrogen
Anti-Mouse IgGAM Polyclonal Antibody, Horseradish Peroxidase Conjugated from Invitrogen
Biology Products: